NSPR InspireMD Inc

$NSPR Similar to the run up before Q2 earnings when we expected fda approval, i'm expecting something similar very soon. New job openings show that approval is imminent for both CGuard Prime AND TCAR designation.

$NSPR three territory manager positions opened up today via LinkedIn. Approvals seem imminent.

$NSPR Earnings pre market is in itself good news. With prime refunds and returns fully realized last quarter, and increasing international sales, AND pending US recommercialization, AND tcar approval expected by the earnings call, i think we are about to say goodbye to pennies and regain compliance.

$NSPR at least we have a date for Q3 updates on 11/12 with pre-market call. Hopefully TCAR approval still on track for early Nov as mentioned in Sep presentation so that news hits before the call in addition to re-commercialization. If they secure TCAR approval and funding from the amended warrants, the stock should be trading much higher than current levels. Also, not sure what to make of the recent uptick in volume but typically volume precedes price action so being at such low prices pending approval should move higher from here.

$NSPR Anyone else wonder what they do all day at InspireMD? I mean you have a payroll that is enormous sitting around accomplishing nothing. Literally nothing. No product - just waiting on the FDA to ask them another question that should have already been answered. The FDA is not some mystical organization. MOST ..like MOST questions they ask are questions you should have already answered. The incompetence is mind boggling.

$NSPR This is one prediction I'd hope to have missed. If I am going to invest more, it will be after the news of FDA approval of original delivery system or new (and any re-commercialization news and any forthcoming RS+Dilution crap. Saying nothing = doing nothing in the market's estimation, and for NSPR, at present, that means the one trick pony is stuck in the stable.

$NSPR Starting to concern me how long it is taking to get FDA clearance on the legacy delivery system. There has to be something they are not telling us. It was used in the trials and in over 70,000 procedures world wide....and we are past the 'typical' timeframe for approval.

$NSPR Trying to just accept it is what it is. Our quarterback sucks at everything quarterback. Slosman is the wrong guy at the right time for the job. He has perpetually failed. He has allowed NSPR to be where it is. He just isnt a good CEO by any metric in the financial realm. He is HORRIFIC at all things FDA. He is a FAILURE at all things a Shareholder would want..MINIMUM communication --always the mininmum. Just hate this guy having so much control over an opportunity. Spend thrift by nature . He lacks wisdom. If that was not the case you would see it in the stock price over a significant amount of time. We have a POS CEO and it shows everyday in what he is communicating to the market. It is what it is. This sucks.

$NSPR don’t worry, loyal shark says the next RS will really be the one to draw institutional investors 😂 🤡

$NSPR FDA approval will no longer save this company. They have basically zero cash runway for any launch and still lose money even they are selling. Why would anyone invest the millions it will take to successfully launch and turn profitable with this kind of incompetent organisation, why you would anyone buy this company to infect themselves with these people. still say bankruptcy and a sell off of the IP.

$NSPR 20 M market share? They'll be doing twice that in annual sales once we get TCAR approval.

$NSPR I can't think of a single reason why anyone would invest in this company even with FDA approval. The company literally has no money to launch and get this thing to scale and profitable. Cheaper to just buy out the company and integrate the IP, yet at 22 million MC, nobody is buying. Something ain't right.

$NSPR calling anyone but a lawyer won't make any difference....this canoe is sinking and only con man Marvin has a lifejacket...the end is near

$NSPR And, there it is. Under $.50 per share for a best in class tech device. All due to mismanagement of the creation and launch of the new delivery system for the US Market. Congratulations NSPR Leadership on being most un-inspiring with your ineffective address and resolution of this key issue, to date. Keep this up and absent of or inclusive of a reverse split, the stock will be between $.30-35 per share (or the reverse split equivalent) with tax loss selling by Dec 31.

$NSPR don’t look at me, I’ve been warning against this cat turd for years. Some cheerleaders even poked at me for my number of followers and such. 😂😂 rah rah sis boom bah. This old, wise guy at the end of the bar doesn’t need to win a Stocktwits popularity contest 😂😂🍻

$NSPR astonishing. For something with so many positives they really managed to shit the bed 😂

$NSPR it took the original PMA 280 days to get approved. Inspiremd announced the expected approval in Q3 or May 1st which would be 179 days since that announcement. NSPR's filing says it submitted the original CGuard EPS PMA in Q1 so if we assume the last possible day in Q1 (March 31st) we would be at 210 days. Just finding the numbers interesting and how they add up.

$NSPR waking up this afternoon and about time it doesn't end the day at a new low. Do the long-termers here think the amended warrants will be exercised after TCAR approval given how far the stock has fallen since the amendment was announced? If so, that should be a major positive catalyst with both the approval and funding at big premium to current price

$NSPR a lot of shares getting traded in the first hour today. Someone’s accumulating for a pop

$NSPR a big question mark is will doctors that were trained on the recalled delivery system need retrained on the original which wasn’t stated by Marvin.